Pharma Journalist - Page 65 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Allarity Therapeutics and FivepHusion Announce Collaboration to Support Clinical Development of Deflexifol with DRP Companion Diagnostics

Sygnature Discovery accelerates global growth with major North American acquisition

Re-designing U.S. Health Insurance

AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets

European Commission Approves Gilead’s Trodelvy For Pre-Treated HR+/HER2- Metastatic Breast Cancer

InSilicoTrials and Axoltis Pharma Collaborate to Advance Therapeutic Solutions for Neurological Disorders

Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development

Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement

Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases

LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis